Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy

Francesco A. Mistretta; Elio Mazzone; Carlotta Palumbo; Sophie Knipper; Zhe Tian; Sebastiano Nazzani; Jean Baptiste Lattouf; Gennaro Musi; Paul Perrotte; Emanuele Montanari; Shahrokh F. Shariat; Francesco Montorsi; Fred Saad; Ottavio de Cobelli; Pierre I. Karakiewicz

doi:10.1016/j.clgc.2019.04.015

Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy

Francesco A. Mistretta
, Elio Mazzone
, Carlotta Palumbo
, Sophie Knipper
, Zhe Tian
, Sebastiano Nazzani
, Jean Baptiste Lattouf
, Gennaro Musi
, Paul Perrotte
, Emanuele Montanari
, Shahrokh F. Shariat
, Francesco Montorsi
, Fred Saad
, Ottavio de Cobelli
, Pierre I. Karakiewicz

Research output: Contribution to journal › Article › peer-review

Abstract

Within the Surveillance, Epidemiology, and End Results database (1988-2015) we identified 11,206 stage I testicular seminoma patients, who underwent respectively surveillance (40%), chemotherapy (CHT; 8%), or radiotherapy (RT; 52%) after orchiectomy. Surveillance and CHT rates increased over time, whereas RT rates decreased. A protective effect of active treatment defined as either RT or CHT was identified on cancer-specific mortality, relative to surveillance.

Original language	English
Pages (from-to)	e793-e801
Journal	Clinical Genitourinary Cancer
Volume	17
Issue number	4
DOIs	https://doi.org/10.1016/j.clgc.2019.04.015
Publication status	Published - Aug 2019
Externally published	Yes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

SDG 3 Good Health and Well-being

Keywords

Chemotherapy
Radiotherapy
SEER program
Surveillance
Testicular neoplasm

Access to Document

10.1016/j.clgc.2019.04.015

Cite this

Mistretta, F. A., Mazzone, E., Palumbo, C., Knipper, S., Tian, Z., Nazzani, S., Lattouf, J. B., Musi, G., Perrotte, P., Montanari, E., Shariat, S. F., Montorsi, F., Saad, F., de Cobelli, O., & Karakiewicz, P. I. (2019). Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy. Clinical Genitourinary Cancer, 17(4), e793-e801. https://doi.org/10.1016/j.clgc.2019.04.015

@article{a757f350d0ad4cbcb1955e17b28f2dd6,

title = "Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy",

abstract = "Within the Surveillance, Epidemiology, and End Results database (1988-2015) we identified 11,206 stage I testicular seminoma patients, who underwent respectively surveillance (40\%), chemotherapy (CHT; 8\%), or radiotherapy (RT; 52\%) after orchiectomy. Surveillance and CHT rates increased over time, whereas RT rates decreased. A protective effect of active treatment defined as either RT or CHT was identified on cancer-specific mortality, relative to surveillance.",

keywords = "Chemotherapy, Radiotherapy, SEER program, Surveillance, Testicular neoplasm",

author = "Mistretta, \{Francesco A.\} and Elio Mazzone and Carlotta Palumbo and Sophie Knipper and Zhe Tian and Sebastiano Nazzani and Lattouf, \{Jean Baptiste\} and Gennaro Musi and Paul Perrotte and Emanuele Montanari and Shariat, \{Shahrokh F.\} and Francesco Montorsi and Fred Saad and \{de Cobelli\}, Ottavio and Karakiewicz, \{Pierre I.\}",

note = "Publisher Copyright: {\textcopyright} 2019 Elsevier Inc.",

year = "2019",

month = aug,

doi = "10.1016/j.clgc.2019.04.015",

language = "English",

volume = "17",

pages = "e793--e801",

journal = "Clinical Genitourinary Cancer",

issn = "1558-7673",

publisher = "Elsevier Inc.",

number = "4",

}

Mistretta, FA, Mazzone, E, Palumbo, C, Knipper, S, Tian, Z, Nazzani, S, Lattouf, JB, Musi, G, Perrotte, P, Montanari, E, Shariat, SF, Montorsi, F, Saad, F, de Cobelli, O & Karakiewicz, PI 2019, 'Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy', Clinical Genitourinary Cancer, vol. 17, no. 4, pp. e793-e801. https://doi.org/10.1016/j.clgc.2019.04.015

Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy. / Mistretta, Francesco A.; Mazzone, Elio; Palumbo, Carlotta et al.
In: Clinical Genitourinary Cancer, Vol. 17, No. 4, 08.2019, p. e793-e801.

Research output: Contribution to journal › Article › peer-review

TY - JOUR

T1 - Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma

T2 - A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy

AU - Mistretta, Francesco A.

AU - Mazzone, Elio

AU - Palumbo, Carlotta

AU - Knipper, Sophie

AU - Tian, Zhe

AU - Nazzani, Sebastiano

AU - Lattouf, Jean Baptiste

AU - Musi, Gennaro

AU - Perrotte, Paul

AU - Montanari, Emanuele

AU - Shariat, Shahrokh F.

AU - Montorsi, Francesco

AU - Saad, Fred

AU - de Cobelli, Ottavio

AU - Karakiewicz, Pierre I.

PY - 2019/8

Y1 - 2019/8

N2 - Within the Surveillance, Epidemiology, and End Results database (1988-2015) we identified 11,206 stage I testicular seminoma patients, who underwent respectively surveillance (40%), chemotherapy (CHT; 8%), or radiotherapy (RT; 52%) after orchiectomy. Surveillance and CHT rates increased over time, whereas RT rates decreased. A protective effect of active treatment defined as either RT or CHT was identified on cancer-specific mortality, relative to surveillance.

AB - Within the Surveillance, Epidemiology, and End Results database (1988-2015) we identified 11,206 stage I testicular seminoma patients, who underwent respectively surveillance (40%), chemotherapy (CHT; 8%), or radiotherapy (RT; 52%) after orchiectomy. Surveillance and CHT rates increased over time, whereas RT rates decreased. A protective effect of active treatment defined as either RT or CHT was identified on cancer-specific mortality, relative to surveillance.

KW - Chemotherapy

KW - Radiotherapy

KW - SEER program

KW - Surveillance

KW - Testicular neoplasm

UR - https://www.scopus.com/pages/publications/85066808004

U2 - 10.1016/j.clgc.2019.04.015

DO - 10.1016/j.clgc.2019.04.015

M3 - Article

SN - 1558-7673

VL - 17

SP - e793-e801

JO - Clinical Genitourinary Cancer

JF - Clinical Genitourinary Cancer

IS - 4

ER -

Contemporary Assessment of Survival Rates in Stage I Testicular Seminoma: A Population-Based Comparison Between Surveillance and Active Treatment After Orchiectomy

Abstract

UN SDGs

Keywords

Access to Document

Other files and links

Fingerprint

Cite this